Vera Therapeutics (VERA) Competitors $48.31 +1.28 (+2.72%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VERA vs. RDY, PCVX, CTLT, SRPT, QGEN, RVMD, ITCI, ROIV, ASND, and LEGNShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), Catalent (CTLT), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Revolution Medicines (RVMD), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. Dr. Reddy's Laboratories Vaxcyte Catalent Sarepta Therapeutics Qiagen Revolution Medicines Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Legend Biotech Vera Therapeutics (NASDAQ:VERA) and Dr. Reddy's Laboratories (NYSE:RDY) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Which has stronger earnings & valuation, VERA or RDY? Dr. Reddy's Laboratories has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than Dr. Reddy's Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$95.99M-$2.61-18.51Dr. Reddy's Laboratories$3.35B3.54$668M$0.6322.69 Does the MarketBeat Community believe in VERA or RDY? Dr. Reddy's Laboratories received 285 more outperform votes than Vera Therapeutics when rated by MarketBeat users. However, 63.16% of users gave Vera Therapeutics an outperform vote while only 59.55% of users gave Dr. Reddy's Laboratories an outperform vote. CompanyUnderperformOutperformVera TherapeuticsOutperform Votes3663.16% Underperform Votes2136.84% Dr. Reddy's LaboratoriesOutperform Votes32159.55% Underperform Votes21840.45% Do analysts recommend VERA or RDY? Vera Therapeutics currently has a consensus target price of $59.22, suggesting a potential upside of 22.59%. Dr. Reddy's Laboratories has a consensus target price of $17.00, suggesting a potential upside of 19.68%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Vera Therapeutics is more favorable than Dr. Reddy's Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10Dr. Reddy's Laboratories 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals have more ownership in VERA or RDY? 99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 14.0% of Dr. Reddy's Laboratories shares are held by institutional investors. 21.7% of Vera Therapeutics shares are held by company insiders. Comparatively, 2.0% of Dr. Reddy's Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to VERA or RDY? In the previous week, Vera Therapeutics had 9 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 10 mentions for Vera Therapeutics and 1 mentions for Dr. Reddy's Laboratories. Dr. Reddy's Laboratories' average media sentiment score of 0.62 beat Vera Therapeutics' score of 0.52 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Dr. Reddy's Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is VERA or RDY more profitable? Dr. Reddy's Laboratories has a net margin of 17.81% compared to Vera Therapeutics' net margin of 0.00%. Dr. Reddy's Laboratories' return on equity of 18.53% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -50.13% -39.50% Dr. Reddy's Laboratories 17.81%18.53%13.01% Which has more risk and volatility, VERA or RDY? Vera Therapeutics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, Dr. Reddy's Laboratories has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. SummaryVera Therapeutics and Dr. Reddy's Laboratories tied by winning 9 of the 18 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.06B$7.00B$5.38B$8.84BDividend YieldN/A8.11%5.13%4.09%P/E Ratio-18.5111.01105.0417.81Price / SalesN/A361.871,235.79158.52Price / CashN/A52.5940.3536.29Price / Book10.5910.377.086.50Net Income-$95.99M$153.60M$119.58M$226.22M7 Day Performance4.43%4.59%2.25%4.03%1 Month Performance21.11%-6.28%-2.34%4.92%1 Year Performance267.10%33.39%33.95%29.30% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics2.5961 of 5 stars$48.31+2.7%$59.22+22.6%+267.1%$3.06BN/A-18.5140Analyst ForecastRDYDr. Reddy's Laboratories1.4214 of 5 stars$13.99-2.2%$17.00+21.5%+5.0%$11.68B$3.35B22.3527,048PCVXVaxcyte3.3258 of 5 stars$88.39+2.8%$147.50+66.9%+80.7%$11.02BN/A-19.22160Positive NewsHigh Trading VolumeCTLTCatalent3.0832 of 5 stars$59.66+1.1%$63.40+6.3%+54.0%$10.83B$4.38B-26.4016,900Analyst DowngradeSRPTSarepta Therapeutics4.9633 of 5 stars$110.50-0.3%$181.33+64.1%+36.4%$10.55B$1.24B88.401,314Analyst DowngradeQGENQiagen4.2795 of 5 stars$42.33+0.6%$50.88+20.2%+2.1%$9.66B$1.97B108.385,967RVMDRevolution Medicines2.8269 of 5 stars$56.78-0.5%$61.00+7.4%+164.7%$9.55B$11.58M-15.82443ITCIIntra-Cellular Therapies4.4537 of 5 stars$85.45-0.2%$97.23+13.8%+44.6%$9.08B$612.78M-98.22560Positive NewsROIVRoivant Sciences3.337 of 5 stars$11.86+3.2%$17.93+51.2%+39.2%$8.77B$124.79M2.09860Insider TradeASNDAscendis Pharma A/S2.9978 of 5 stars$123.02-1.1%$191.77+55.9%+39.6%$7.54B$327.43M-15.22640Analyst UpgradeLEGNLegend Biotech1.4452 of 5 stars$39.75-1.0%$81.46+104.9%-31.9%$7.25B$285.14M-41.841,800 Related Companies and Tools Related Companies Dr. Reddy's Laboratories Competitors Vaxcyte Competitors Catalent Competitors Sarepta Therapeutics Competitors Qiagen Competitors Revolution Medicines Competitors Intra-Cellular Therapies Competitors Roivant Sciences Competitors Ascendis Pharma A/S Competitors Legend Biotech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERA Stock Alerts